For Wednesday, August 10th
NEOM, HIRU, MBYL, GOIG, BBDA, OXGN
Our Stocks to Watch today include NeoMedia Technologies Inc. (OTCBB: NEOM), Hiru Corp. (OTC: HIRU), Mobile Data Corp. (OTCBB: MBYL), GOIP Global Inc. (OTC: GOIG), Bebida Beverage Co. (OTC: BBDA) and OXiGENE Inc. (Nasdaq: OXGN).
STOCKS TO WATCH
NEOMEDIA TECHNOLOGIES INCORPORATED (OTCBB: NEOM)
"Up 21.25% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/NEOM.php
NeoMedia Technologies, Inc. is the global leader in mobile barcode scanning solutions. The company's technology allows mobile devices with cameras to read 1D and 2D barcodes and provide “one click” access to mobile content. Combining this technology with advanced analytics and reporting capabilities revolutionizes the way advertisers market to mobile consumers. NeoMedia provides the infrastructure to make 2D camera barcode scanning and its associated commerce easy, universal, and reliable — worldwide.
NEOM News:
July 22 - NeoMedia Appoints Corporate Controller as New Interim CFO
Announces Resignation of Chief Financial Officer
NeoMedia™ Technologies, Inc. (OTCBB: NEOM), the global leader in mobile barcode scanning solutions, today announced that Mike Zima, the Company’s Chief Financial Officer (“CFO”), has tendered his resignation. Robert Thomson, the current Corporate Controller, has been appointed by the Company’s Board of Directors as interim CFO with immediate effect.
"We would like to thank Mike for his contribution to NeoMedia and wish him well," said Laura Marriott, CEO and Chairperson of the Board, NeoMedia. “We are looking forward to working with Robert in his new role, which we know he has the right experience and skills to seamlessly transition into. It is an exciting time for NeoMedia as we maximize the opportunities for the organization in the emerging mobile barcode ecosystem.”
Mr. Thomson has been Corporate Controller at NeoMedia since September 2008 and as such has been one of the key members of the executive team responsible for the organization’s financial activities. Prior to joining NeoMedia, Thomson served as Corporate Controller for Charys Holding Company, Inc., providing oversight to the organization’s corporate accounting structure and integration of newly acquired subsidiary companies. Mr. Thomson has also held executive roles at Technologies Solutions Corp., MemberCall Business Communication Services, Tel3.com, Inc., and American Telnet, with over fifteen years for corporate finance management experience.
HIRU CORPORATION (OTC: HIRU)
"Up 25.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/HIRU.php
Here Enterprises is a developer of wind power, our nation's fastest growing renewable energy resource. The Company is engaged in planning, developing, acquiring and operating wind farms in the United States to generate clean, profitable wind energy. Here Enterprises is developing wind energy projects which co-locate wind farms with commercial businesses in order to maximize cashflow for each project.
HRTE News:
August 1 - MindUp BioResearch (HIRU) Research Team Published Their New Results on the Topic of Overcoming Multiple-Drug Resistance in Lung Cancer Therapy
Hiru Corporation (OTC: HIRU) announced that researchers from its MindUp BioResearch (www.mindupbioresearch.com), European subsidiary have published their new results of preclinical studies on the topic of overcoming multidrug resistance, a frequent phenomenon occurring in cancer that seriously limit the efficacy of lung cancer course of therapy with chemotherapeutic agents.
Dr Sabera Ruzdijic, the Leader of MindUp Bioresearch Group said: "In this paper we examined the effect of two purine analogs sulfinosine (SF) and 8-Cl-cAMP on cell growth inhibition in parental and resistant human lung carcinoma cell lines. Pretreatment with purine analogues was more potent in improving the sensitivity of resistant lung carcinoma cells to doxorubicin than conventional chemo-sensitizing agent - verapamil (VER). Combinations of either SF or 8-Cl-cAMP with VER at clinically acceptable concentrations exhibited synergistic effects on cell growth inhibition in the resistant lung carcinoma cell line. Together with their ability to reverse multidrug resistance, these results render the purine analogs (in combination with VER) as potential candidates for improving the clinical activity of existing lung cancer therapeutics.
Dr Sabera Ruzdijic added: "We are proud that these results are accepted and published in the prestigious journal Investigational New Drugs (2010) 28:482-492 by Pesic et al. At the company website www.hirucorporation.com you can find the PDF of article.”
In other company news and updates, MindUp division is currently in negotiation discussions as a buyout candidate. The management is of the opinion that this is a material event that warrants a news release.
More details will follow on the MindUp divestiture as it becomes available.
MOBILE DATA CORPORATION (OTCBB: MBYL)
"Up 5.66% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MBYL.php
Mobile Data Corp. operates as an independent software development company whose mandate is to provide solutions for telecommunications and computer convergence. Its technology is a software application that would run in the background and would collect and transmit location data to a server. The company was formerly known as Endeavor Explorations Inc. and changed its name to Mobile Data Corp. in January 2010. Mobile Data Corp. is based in San Jose, California.
MYBL News:
August 9 - Mobile Data Corp. Completes Due Diligence of Unique Social Media Application and Enters Into Asset Purchase Agreement; Initial Product Launch and Release Planned for Facebook®
Mobile Data Corp. (OTCBB: MBYL) ("MDC") announces the completion of due diligence in connection with a recent Letter Agreement entered into with BEET Company Ltd. ("BEET") to acquire certain assets from BEET for the development of an application for use in various social media initiatives.
MDC has determined that the application under review met the necessary criteria for MDC to become involved in furthering what is essentially the 'last mile' development of the software application and introducing it to the social media marketplace. As a result, MDC has entered into a definitive agreement with BEET to acquire the assets and immediately begin the process of completing final development of the application. Given its current stage of development, MDC expects that it will be able to complete the necessary 'last mile' programming of the application and beta test it in under 30 days.
Furthermore, MDC is pleased to announce that once the application is completed and tested, it plans to initially launch it and make it available to the members of Facebook®. Facebook® is a natural fit for MDC's new software application - which has yet to be named - as it is the preeminent social media platform and recently reported it has over 750 million members worldwide. The MDC application for Facebook® is an application that could conceivably be utilized by every member of Facebook® whether they are an individual, corporation, informal group or formal organization.
Mobile is a solutions provider for telecommunications and computer convergence technology. MDC previously developed the "MDCTracker™", and the "MDC-KidTracker™" child safety application for BlackBerry® Smartphones. MDC is committed to acquiring and developing software applications to provide real solutions that address real issues. Developing products for use in social media forums is a natural progression of the MDC's overall business and corporate strategy.
GOIP GLOBAL INCORPORATED (OTC: GOIG)
"Up 28.57% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/GOIG.php
GoIP Global offers a range of services, solutions and tools for brands, agencies, content providers, online portals, entertainment and media companies. GoIP Global offers brand and content customers great flexibility in creating mobile marketing campaigns and applications. Through its subsidiary GO800, LLC, GO800™, a new patent pending text messaging service, which launched in 2010, enables advertisers to incorporate a text prompt in their advertisements, prompting consumers to contact them through a text message rather than calling a 1-800 toll free number.
GOIG News:
August 9 - GOIP Updates Shareholders
GOCOM Spinoff Record Date July 29, 2011
GOIP Global, Inc. (OTC: GOIG) announced that the spinoff of GOCOM Corporation (formerly Go800 LLC) has been completed with a record date of July 29, 2011.
Per the spin-off, shareholders of GOIP common stock will receive a dividend of one (1) share of common stock of GOCOM for each 625 shares of GOIP common stock ("Distribution Ratio") owned as of the close of business on July 29, 2011 (the "Record Date"). No distribution will be made of one (1) share or less; instead, shareholders who would be entitled to receive one (1) share of GOCOM common stock or less will receive a cash payment of $3.00. The stock dividend is expected to be distributed by January 1, 2012.
All shareholders will be sent an Information Statement which will be posted on Pink Sheets on August 10, 2011. The Information Statement will address most questions shareholders may have.
GOIP's audited financials for the year ending September 30, 2010 and 2009 as well as the June 30, 2011 Quarterly Report will be posted on Pink Sheets the week of August 15.
On Thursday, August 25, the company's CEO will have a shareholder's conference call outlining the future plans for GOIP Global. More information about the conference call, time and number to follow.
BEBIDA BEVERAGE COMPANY (OTC: BBDA)
"Up 2.56% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BBDA.php
BeBevCo (Bebida Beverage Company) develops, manufactures and markets beverages including Koma Unwind "Chillaxation Drink™," Koma Unwind Sugar-free "Chillaxation Drink™," and Koma Unwind "Chillaxation Shot™" as well as Potencia Energy Drink, Potencia "BLAST" energy shot and Piranha Water.
BBDA News:
July 6 - BeBevCo Announces KOMA UNWIND Relaxation Drink Advances to California
Bebida Beverage Co. (OTC: BBDA) (BeBevCo), a developer, manufacturer and marketer of relaxation and energy drinks, announced today that the Company has signed a distribution agreement with Innovative Products which is bringing the drink to Santa Ana, California. Delivery of KOMA UNWIND relaxation drink (Chillaxation Drink™) and KOMA UNWIND 2 oz Relaxation Shots will begin next week to specialty stores and convenience stores in the Los Angeles suburb.
"KOMA UNWIND is on fire; we are having a hard time keeping up with all of the calls and enquiries about the drink. Obviously we are very pleased to have distribution in California for the first time. We expect to have more significant news over the coming weeks regarding more distribution deals with prominent distribution companies," said BeBevCo CEO Brian Weber. "The biggest change over the last couple of weeks has been the number of requests from individuals wanting to buy KOMA UNWIND all over the country. We are just telling them to go to their local stores and distributors and ask them to start stocking it. Feedback has been outstanding as well and we expect a lot more given that people are spending hundreds of millions of dollars on sleep and anxiety solutions; KOMA UNWIND is a great alternative," emphasized Weber.
"Any retailers who wish to sell KOMA UNWIND or Potencia Blast Energy Shots should contact us," added Daisy Ramirez, BeBevCo COO.
OXIGENE INCORPORATED (NASDAQ: OXGN)
"Up 10.34% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/OXGN.php
OXiGENE, Inc. develops small-molecule therapeutics to treat cancer and eye diseases in the United States. It focuses on the development and commercialization of drug candidates that disrupt abnormal blood vessels associated with solid tumor progression and visual impairment in ocular diseases. The company's product ZYBRESTAT, is in Phase II/III pivotal registration study as a potential treatment for anaplastic thyroid cancer, as well as in Phase Ib and II clinical trials for other solid tumors, including non-small cell lung cancer, platinum resistant ovarian cancer, and head-and-neck cancer. It also develops a topical formulation of ZYBRESTAT for ophthalmological diseases and conditions, such as age-related macular degeneration. In addition, OXiGENE develops OXi4503, an ortho-quinone prodrug, which is in Phase I clinical trial for solid tumors. The company was founded in 1988 and is headquartered in Waltham, Massachusetts.
OXGN News:
August 3 - OXiGENE Reports Second Quarter 2011 Financial Results
OXiGENE, Inc. (Nasdaq: OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report second quarter 2011 results on Wednesday, August 10, 2011. A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm EDT (1:30 p.m. PDT).
To listen to a live or an archived version of the audio webcast, please log on to the Company's website, www.oxigene.com. Under the "Investors" tab, select the link to "Events & Presentations."
OXiGENE's earnings conference call can also be heard live by dialing (888) 841-3431 in the United States and Canada, and +1 (678) 809-1060 for international callers, five minutes prior to the beginning of the call. A replay will be available starting at 7:30 p.m. EDT, (4:30 p.m. PDT) on August 10, 2011 and ending at midnight EDT (9:00 p.m. PDT) on Tuesday, August 16, 2011. To access the replay, please dial (855) 859-2056 if calling from the United States or Canada, or +1 (404) 537-3406 from international locations. Please refer to replay pass code 88795709.
|
